Revive Therapeutics clarifies status of phase 3 study of Bucillamine in COVID-19
January 06 2022 - 4:51PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Revive Therapeutics (QB) (USOTC:RVVTF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Revive Therapeutics (QB) (USOTC:RVVTF)
Historical Stock Chart
From Apr 2023 to Apr 2024